The daily dose: June 30, 2021

PT Jyothi Datta | Updated on June 30, 2021

# India is set to get its first mRNA vaccine, albeit through a donation, from Moderna. And drugmaker Cipla will facilitate the through-pass. That said, it paves the way for more strategic partnerships to bring next-gen vaccines into the country.

# Staying with vaccines, Indian Immunologicals makes progress with its Covid-19 vaccine, as it seeks regulatory approvals for early phase human trials.

# The EU “green-pass” has been causing much heartburn for Indians vaccinated with Serum Institute’s Covishield. But here’s a clarification from official sources.

# And here’s what the European regulatory authority on medicines and vaccines has to say on it. Unnecessary anxiety, say industry-insiders, specially when Covishield is deployed in the UK and has a WHO listing for emergency use as well.

# Domestic pharma majors explore collaborative research on a Covid-19 drug. A first time for the sector, heralds interesting times ahead ....

Published on June 30, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like